Development of an Electromyography Signal Acquisition Prototype and Statistical Validation Against a Commercial Device.

Electromyography (EMG) stands out as an accessible and inexpensive method for identifying muscle contractions on the surface and within deeper muscle tissues. Using specialized electronic circuits for amplification and filtering can help develop simple but effective systems for detecting and analyzing these signals. However, EMG devices developed by research teams frequently lack rigorous methodologies for validating the quality of the signals they record compared to those obtained by commercial systems that have undergone extensive testing and regulatory approval for market release. This underscores the critical need for standardized validation techniques to reliably assess the performance of experimental devices relative to established commercial equipment. Hence, this study introduces a methodology for the development and statistical validation of a laboratory EMG circuit compared with a professional device available on the market. The experiment simultaneously recorded the muscle electrical activity of 18 volunteers using two biosignal acquisition devices-a prototype EMG and a commercial system-both applied in parallel at the same recording site. Volunteers performed a series of finger and wrist extension movements to elicit myoelectric activity in these forearm muscles. To achieve this, it was necessary to develop not only the EMG signal conditioning board, but also two additional interface boards: one for enabling parallel recording on both devices and another for synchronizing the devices with the task programmatically controlled in Python that the volunteers were required to perform. The EMG signals generated during these tasks were recorded simultaneously by both devices. Subsequently, 22 feature indices commonly used for classifying muscular activity patterns were calculated from two-second temporal windows of the recordings to extract detailed temporal and spatial characteristics. Finally, the Mean Absolute Percentage Error (MAPE) was computed to compare the indices from the prototype with those from the commercial device, using this method as a validation system to assess the quality of the signals recorded by the prototype relative to the commercial equipment. A concordance of 87.6% was observed between the feature indices calculated from the recordings of both devices, suggesting high effectiveness and reliability of the EMG signals recorded by the prototype compared to the commercial device. These results validate the efficacy of our EMG prototype device and provide a solid foundation for the future evaluation of similar devices, ensuring their reliability, accuracy, and suitability for research or clinical applications.